Longevity & Health
Longevity & Health
Aging biology, GLP-1, diagnostics, and ML moving into the clinic.
State of the world · updated June 2026
Right now: GLP-1 drugs are the breakout, with effects being mapped well beyond weight. Epigenetic clocks are maturing into usable readouts, and AI-bio labs are shortening the discovery loop.
Watch: whether partial cellular reprogramming stays safe outside the lab, and how much of the GLP-1 "everything drug" story survives larger trials.
Start here · the primer
The throughline is convergence: aging is starting to look engineerable, and ML is the microscope. GLP-1 drugs cracked behaviour change; epigenetic clocks gave a readout; foundation models are compressing the discovery loop.